<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H791EB6B36E60430FA2BD5AA939989567" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 4623 IH: Plain Prescription Prices Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-07-22</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 4623</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250722">July 22, 2025</action-date><action-desc><sponsor name-id="W000788">Ms. Williams of Georgia</sponsor> (for herself, <cosponsor name-id="B001298">Mr. Bacon</cosponsor>, <cosponsor name-id="C001119">Ms. Craig</cosponsor>, and <cosponsor name-id="S001213">Mr. Steil</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HWM00">Ways and Means</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To require direct-to-consumer advertisements for prescription drugs and biological products to include truthful and not misleading pricing information.</official-title></form><legis-body id="HF83C504F2D0B4195A45D74841F41A43E" style="OLC"><section id="H5908373CDBC74B549B0A88004008C3FC" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Plain Prescription Prices Act</short-title></quote>. </text></section><section id="H4E53BDE63EEC4881B9A7BF95E7D20FAD" section-type="subsequent-section"><enum>2.</enum><header>Regulating advertisements for prescription drug and biological product prices</header><subsection id="H417B27B410154CFEBA7011B069051FFF"><enum>(a)</enum><header>In general</header><text>Not later than one year after the date of the enactment of this Act, the Secretary of Health and Human Services, acting through the Administrator of the Centers for Medicare &amp; Medicaid Services (referred to in this section as the <quote>Administrator</quote>), shall promulgate regulations requiring each direct-to-consumer advertisement on television (including broadcast, cable, streaming, and satellite television) for a prescription drug or biological product for which payment is available under title XVIII or XIX of the Social Security Act to include a textual statement, which shall be truthful and not misleading, indicating the list price, as determined on the first day of the quarter during which the advertisement is being aired or otherwise broadcast, for a typical 30-day regimen or typical course of treatment (whichever is most appropriate).</text></subsection><subsection id="HA05ECC2B343F4E30A7F0A52CBA7D8444"><enum>(b)</enum><header>Determinations</header><text>In promulgating regulations under subsection (a), the Administrator shall determineâ€”</text><paragraph id="H4FAC92D296564411A71564DB31F97B12"><enum>(1)</enum><text>whether such regulations should apply with respect to additional forms of advertising;</text></paragraph><paragraph id="H13B2A4BC0A4049BDAA2E55AA103483EE"><enum>(2)</enum><text>the manner and format of textual statements described in such subsection;</text></paragraph><paragraph id="HBFF12945EFB44AE2B78ADC4871D44448"><enum>(3)</enum><text>appropriate enforcement mechanisms; and</text></paragraph><paragraph id="H0C7D3F87C8A34AC59642A17D2BEF4FCF"><enum>(4)</enum><text>whether such textual statements should include any other price information, as appropriate.</text></paragraph></subsection></section></legis-body></bill> 

